Publication | Closed Access

ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor

Lymphoid NeoplasiaAutoimmune DiseaseImmunodeficienciesPathogenesisAutophagyImmunologyPathologyLymphatic SystemAutoimmunityMek InhibitorLymphatic AnomalyLymphatic DiseaseMedicineCell SignalingInborn Error Of ImmunityAraf Recurrent Mutation